Post-approval Considerations for Changes to Manufacturing Process and Facilities - REdI 2020

  Рет қаралды 12,798

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Пікірлер
eCTD (7/28) Generic Drugs Forum 2017
17:16
eCTD (7/28) Generic Drugs Forum 2017
U.S. Food and Drug Administration
Рет қаралды 779
Lifecycle Changes to Chemistry, Manufacture, and Controls in NDAs - REdI 2020
34:37
Lifecycle Changes to Chemistry, Manufacture, and Controls in NDAs - REdI 2020
U.S. Food and Drug Administration
Рет қаралды 3,8 М.
ЧТО ОПАСНЕЕ? ОТВЕТЫ ВАС ШОКИРУЮТ... (1% ОТВЕЧАЮТ ПРАВИЛЬНО) #Shorts #Глент
00:38
ЧТО ОПАСНЕЕ? ОТВЕТЫ ВАС ШОКИРУЮТ... (1% ОТВЕЧАЮТ ПРАВИЛЬНО) #Shorts #Глент
ГЛЕНТ
Рет қаралды 2,4 МЛН
Он ждал ДВА ГОДА, чтобы преподать наглецу УРОК СКРОМНОСТИ #shorts
01:00
Он ждал ДВА ГОДА, чтобы преподать наглецу УРОК СКРОМНОСТИ #shorts
BalcevMMA_BOXING
Рет қаралды 10 МЛН
Enceinte et en Bazard: Les Chroniques du Nettoyage ! 🚽✨
00:21
Enceinte et en Bazard: Les Chroniques du Nettoyage ! 🚽✨
Two More French
Рет қаралды 42 МЛН
🎄✨ Puff is saving Christmas again with his incredible baking skills! #PuffTheBaker #thatlittlepuff
00:42
🎄✨ Puff is saving Christmas again with his incredible baking skills! #PuffTheBaker #thatlittlepuff
That Little Puff
Рет қаралды 24 МЛН
So, Your NDA Was Approved - Now What?! Post-approval Responsibilities and Obligations- REdI 2020
58:43
So, Your NDA Was Approved - Now What?! Post-approval Responsibilities and Obligations- REdI 2020
U.S. Food and Drug Administration
Рет қаралды 4,4 М.
CMC Considerations for CAR T Cell Product Development
29:42
CMC Considerations for CAR T Cell Product Development
U.S. Food and Drug Administration
Рет қаралды 12 М.
Common CMC (Quality) Issues and How to Avoid Them Part I (12of16) Generic Drugs Forum
57:58
Common CMC (Quality) Issues and How to Avoid Them Part I (12of16) Generic Drugs Forum
U.S. Food and Drug Administration
Рет қаралды 7 М.
Electronic Common Technical Document (eCTD) and Study Data (7of15) RedI - May 29-30, 2019
55:56
Electronic Common Technical Document (eCTD) and Study Data (7of15) RedI - May 29-30, 2019
U.S. Food and Drug Administration
Рет қаралды 12 М.
ANDA Postapproval Changes: Best Practices and Strategies to Avoid Common Quality Assessment Issues
22:52
ANDA Postapproval Changes: Best Practices and Strategies to Avoid Common Quality Assessment Issues
U.S. Food and Drug Administration
Рет қаралды 5 М.
Overview of the Guidance for Industry: Control of Nitrosamine Impurities in Human Drugs
1:22:14
Overview of the Guidance for Industry: Control of Nitrosamine Impurities in Human Drugs
U.S. Food and Drug Administration
Рет қаралды 16 М.
MEDIA CALL: FDA’s Final Rule on "Healthy" Claim - 12/19/2024
30:15
MEDIA CALL: FDA’s Final Rule on "Healthy" Claim - 12/19/2024
U.S. Food and Drug Administration
Рет қаралды 724
National Drug Code (NDC) for Healthcare Providers
41:59
National Drug Code (NDC) for Healthcare Providers
U.S. Food and Drug Administration
Рет қаралды 701
Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017
1:20:20
Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017
U.S. Food and Drug Administration
Рет қаралды 23 М.
Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA
1:56:59
Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA
U.S. Food and Drug Administration
Рет қаралды 10 М.
ЧТО ОПАСНЕЕ? ОТВЕТЫ ВАС ШОКИРУЮТ... (1% ОТВЕЧАЮТ ПРАВИЛЬНО) #Shorts #Глент
00:38
ЧТО ОПАСНЕЕ? ОТВЕТЫ ВАС ШОКИРУЮТ... (1% ОТВЕЧАЮТ ПРАВИЛЬНО) #Shorts #Глент
ГЛЕНТ
Рет қаралды 2,4 МЛН